Mesoblast (MESO) Return on Equity [ROE] (2016 - 2023)
Mesoblast (MESO) recorded Return on Equity [ROE] of -9.86% in the year ended Jun 30, 2026, up 9.09 percentage points from -18.95% a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Return on Equity [ROE] (2016 - 2023) Analysis & Trends
Starting with the year ended Jun 30, 2015, Mesoblast's Return on Equity [ROE] history includes 12 years.
- Annual Return on Equity [ROE] has a five-year change of +7.61 percentage points (years ended Jun 2021 to Jun 2026).
- The figure for the year ended Jun 30, 2026 is the highest annual Return on Equity [ROE] in data going back to the year ended Jun 30, 2015.
- Per Business Quant data, MESO's Return on Equity [ROE] was -18.95% in the year ended Jun 30, 2025 (-1.04 pp), -17.91% in the year ended Jun 30, 2024 (-1.51 pp), -16.40% in the year ended Jun 30, 2023 (+0.54 pp) and -16.94% in the year ended Jun 30, 2022 (+0.54 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Mesoblast | 1.81 Bn | 1.38 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -16.64% |
| Mar 31, 2023 | -16.58% |
| Dec 31, 2022 | -16.45% |
| Sep 30, 2022 | -16.78% |
| Jun 30, 2022 | -18.01% |
| Mar 31, 2022 | -17.47% |
| Dec 31, 2021 | -17.74% |
| Sep 30, 2021 | -16.99% |
| Jun 30, 2021 | -16.71% |
| Mar 31, 2021 | -19.53% |
| Dec 31, 2020 | -18.56% |
| Sep 30, 2020 | -17.83% |
| Jun 30, 2020 | -15.03% |
| Mar 31, 2020 | -13.36% |
| Dec 31, 2019 | -15.53% |
| Sep 30, 2019 | -15.85% |
| Jun 30, 2019 | -18.29% |
| Mar 31, 2019 | -17.53% |
| Dec 31, 2018 | -16.36% |
| Sep 30, 2018 | -8.90% |
API Access
Mesoblast Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();